Demographics (1)
- SEX - Sex/gender of subject (phv00572435.v1.p2)
Other (14)
- ANALYTE_TYPE - Analyte Type (phv00290103.v2.p2)
- BODY_SITE - Body site where sample was collected (phv00290102.v2.p2)
- CONSENT - Registered consent groups (Data Use Limitations (DUL)) as determined by submitters' Institutional Review Boards (IRB) or equivalent body (phv00290093.v3.p2)
- Funding_Source - Provider of sequencing funding (phv00290107.v2.p2)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00290105.v2.p2)
- IS_TUMOR - Tumor status (phv00290104.v2.p2)
- SAMPLE_ID - De-identified Sample ID (phv00290101.v2.p2)
- SAMPLE_ID - Sample ID (phv00290097.v2.p2)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00290106.v2.p2)
- Study_Name - Name of the dbGaP study cohort (phv00290110.v2.p2)
- SUBJECT_ID - Subject ID (phv00290092.v3.p2)
- SUBJECT_ID - Subject ID (phv00290096.v2.p2)
- TOPMed_Phase - Data release of TOPMed Consortium sequencing (phv00290108.v2.p2)
- TOPMed_Project - Name of the TOPMed Consortium study cohort (phv00290109.v2.p2)